Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non‐Hodgkin's lymphoma

AIMS: The aims of the study were: (i) to characterize the pharmacokinetics (PK) of doxorubicin (DOX) and doxorubicinol (DOXol) in patients diagnosed with non‐Hodgkin's lymphoma (NHL) using a population approach; (ii) to evaluate the influence of various covariates on the PK of DOX; and (iii) to...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Clin Pharmacol
Auteurs principaux: Pérez‐Blanco, Jonás Samuel, Santos‐Buelga, Dolores, Fernández de Gatta, María del Mar, Hernández‐Rivas, Jesús María, Martín, Alejandro, García, María José
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Pharmacokinetics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099548/
https://ncbi.nlm.nih.gov/pubmed/27447545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13070
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires